ES2551157T3 - Uso de glucosilglicerol - Google Patents

Uso de glucosilglicerol Download PDF

Info

Publication number
ES2551157T3
ES2551157T3 ES09778036.5T ES09778036T ES2551157T3 ES 2551157 T3 ES2551157 T3 ES 2551157T3 ES 09778036 T ES09778036 T ES 09778036T ES 2551157 T3 ES2551157 T3 ES 2551157T3
Authority
ES
Spain
Prior art keywords
substances
glucosylglycerol
proteins
allergens
toxins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES09778036.5T
Other languages
English (en)
Inventor
Julia Klein
Gerhard Stumm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bitop AG
Original Assignee
Bitop AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bitop AG filed Critical Bitop AG
Application granted granted Critical
Publication of ES2551157T3 publication Critical patent/ES2551157T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Uso de glucosilglicerol para la preparación de un producto para la protección de la piel y/o la mucosa humanas frente a compuestos de oxígeno reactivos, radicales libres, productos químicos, toxinas, alérgenos, sustancias desnaturalizantes, sustancias que se unen al ADN, sustancias que dañan a las proteínas, sustancias que desactivan proteínas o polvo en suspensión mediante aumento de la expresión de enzimas protectoras de células.

Description

imagen1
imagen2
imagen3
imagen4

Claims (1)

  1. imagen1
ES09778036.5T 2008-08-22 2009-08-21 Uso de glucosilglicerol Active ES2551157T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102008039231A DE102008039231A1 (de) 2008-08-22 2008-08-22 Verwendung von Glucosylglycerol
DE102008039231 2008-08-22
PCT/EP2009/006083 WO2010020424A2 (de) 2008-08-22 2009-08-21 Verwendung von glucosylglycerol

Publications (1)

Publication Number Publication Date
ES2551157T3 true ES2551157T3 (es) 2015-11-16

Family

ID=41566715

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09778036.5T Active ES2551157T3 (es) 2008-08-22 2009-08-21 Uso de glucosilglicerol

Country Status (7)

Country Link
US (2) US9867767B2 (es)
EP (1) EP2328545B1 (es)
JP (1) JP2012500781A (es)
DE (1) DE102008039231A1 (es)
ES (1) ES2551157T3 (es)
PL (1) PL2328545T3 (es)
WO (1) WO2010020424A2 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008537734A (ja) * 2005-03-12 2008-09-25 ビトップ アクツィエンゲゼルシャフト フュール ビオテヒニシェ オプティミールング 経口で用いられる適合溶質を含む薬剤
DE102008039231A1 (de) 2008-08-22 2010-02-25 Bitop Ag Verwendung von Glucosylglycerol
ES2751248T3 (es) 2011-11-24 2020-03-30 Toyo Sugar Refining Co Ltd Agente protector queratoconjuntival o agente inhibidor de trastornos queratoconjuntivales
JP6061474B2 (ja) * 2012-02-17 2017-01-18 東洋精糖株式会社 ラジカルによる蛋白質の変性および／または分解の抑制方法
DE102012013482A1 (de) 2012-07-09 2014-01-09 Bitop Ag Zusammensetzung zur Förderung der Wiederherstellung von verletztem Körpergewebe
JP2014058472A (ja) * 2012-09-18 2014-04-03 Toyo Seito Kk 皮膚老化防止用化粧料
FR2997853B1 (fr) * 2012-11-09 2016-11-04 Oreal Utilisation d'extrait de myrothamnus flabellifolia et de rhamnose pour lutter contre les signes du vieillissement cutane.
JP6077899B2 (ja) * 2013-03-21 2017-02-08 サッポロビール株式会社 アセトアルデヒドデヒドロゲナーゼ阻害剤
US10543158B2 (en) 2017-04-17 2020-01-28 W Skincare, LLC Autophagy activating complex, compositions and methods
CN109998937B (zh) * 2019-03-22 2021-06-29 南京工业大学 含有甘油葡糖苷(αGG)的系列化妆品及其制备方法
JP2020158449A (ja) * 2019-03-27 2020-10-01 東洋精糖株式会社 グルタチオンレダクターゼ発現促進剤、抗酸化能改善剤
JPWO2020196484A1 (es) * 2019-03-28 2020-10-01

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4261995A (en) 1979-08-31 1981-04-14 Syntex (U.S.A.) Inc. 4-Phenyl-and 5-phenyl-1,4,5,6-tetrahydropyrimidine derivatives
EP0053754B1 (de) 1980-12-06 1986-04-23 Reichert, Dietrich, Dr. med. Mittel zur Bekämpfung des Schnarchens und Verfahren zu dessen Anwendung
DE3635522A1 (de) 1986-10-18 1988-04-28 Euro Celtique Sa Pharmazeutische zusammensetzung
SE467340B (sv) 1990-07-04 1992-07-06 Perstorp Ab Anvaendning av inositolmonofosfat foer framstaellning av ett laekemedel effektivt som en neuropeptid y-(npy-)antagonist
FR2674434B1 (fr) 1991-03-27 1993-06-18 Nativelle Sa Ets Nouvelle composition pharmaceutique a base de taurine pour l'administration par inhalation.
IL100810A (en) 1992-01-30 1996-12-05 Yeda Res & Dev Pharmaceutical preparations including 2 - methyl - carboxy - 5 - hydroxy - tetrahydropyrimidine and / or 2 - methyl - 4 - carboxy - tetrahydropyrimidine, plywood methods
IL101056A (en) 1992-02-24 1997-03-18 Res & Dev Co Ltd Composition for nasal treatment
US5834473A (en) 1993-04-29 1998-11-10 Cultor, Ltd. Method for treating coccidiosis
DE4342560A1 (de) 1993-12-14 1995-06-22 Marbert Gmbh Ectoin und Ectoinderivate als Feuchtigkeitsspender in Kosmetikprodukten
DE19540749A1 (de) 1995-11-02 1997-05-07 Beiersdorf Ag Kosmetische Zubereitungen mit einem wirksamen Gehalt an Glycosylglyceriden
US5880098A (en) * 1996-04-12 1999-03-09 Pharmacia & Upjohn Aktiebolag Therapeutic treatment
PT101887A (pt) 1996-06-28 1998-01-30 Inst De Biolog Ex E Tecnologic Utilizacao de 2-0- -manosilglicerato para termoestabilizacao, osmoproteccao e proteccao contra a desidratacao de enzimas, outros componenetes celulares e celulas
DE19634021A1 (de) * 1996-08-23 1998-02-26 Beiersdorf Ag Antiadhäsive Glycoglycerolipide
US20010056068A1 (en) 1998-03-04 2001-12-27 Kristof Chwalisz Method of treatment and prevention of nitric oxide deficiency-related disorders with citrulline and citrulline derivatives
AU750027B2 (en) 1998-08-01 2002-07-11 Merck Patent Gmbh Use of ectoine or ectoine derivatives in cosmetic formulations
US6080401A (en) 1998-11-19 2000-06-27 Reddy; Malireddy S. Herbal and pharmaceutical drugs enhanced with probiotics
EP2191718A1 (en) 1998-12-22 2010-06-02 The University of North Carolina at Chapel Hill Compounds and uses for the treatment of airway diseases and for the delivery of airway drugs
JP2003501479A (ja) * 1999-06-12 2003-01-14 ビトプ ゲゼルシャフト ミット ベシュレンクテル ハフツング 薬 剤
ES2233630T3 (es) * 2000-04-12 2005-06-16 Bitop Aktiengesellschaft Fur Biotechnische Optimierung Uso de solutos compatibles como sustancias con propiedades barredoras de radicales.
US6716819B2 (en) 2000-05-19 2004-04-06 University Of Iowa Research Foundation Use of xylitol to reduce ionic strength and activate endogenous antimicrobials for prevention and treatment of infections
AU2001295469A1 (en) * 2000-08-18 2002-03-04 Bitop Gesellschaft Fur Biotechnische Optimierung Mbh Cosmetic formulation containing at least one di-sugar alcohol phosphate of c3 to c6 sugar alcohols
US7048910B2 (en) 2000-09-07 2006-05-23 Merck Patent Gmbh Use of ectoine or ectoine derivatives for oral care
US20020151541A1 (en) 2000-10-31 2002-10-17 Michel Pairet Pharmaceutical compositions containing tiotropium salts and antihistamines and their use
FR2819411B1 (fr) 2001-01-18 2003-02-21 Oreal Composition cosmetique irisee et ses utilisations
FR2826011B1 (fr) 2001-06-14 2004-12-10 Oreal Nouveaux derives de la 7-oxo-dhea et utilisation cosmetique
DE10133202A1 (de) 2001-07-07 2003-01-16 Beiersdorf Ag Osmolyte enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut
FR2832156B1 (fr) 2001-11-15 2004-05-28 Oreal Preparation de composes de type betainates de polysaccharides, composes obtenus, leur utilisation et les compositions les comprenant
US6485711B1 (en) 2002-03-21 2002-11-26 Michael J. Olmstead Organic toothpaste containing saponin
DE10240923A1 (de) 2002-09-02 2004-03-04 Merck Patent Gmbh Flavonoid-Derivate zur Ekzem-Behandlung
AU2003272517A1 (en) 2002-09-13 2004-04-30 Zicam, Llc. Compositions to reduce congestion and methods for application thereof to the nasal membrane
JP4039567B2 (ja) * 2003-05-08 2008-01-30 株式会社ノエビア 水性化粧料
JP4307148B2 (ja) * 2003-05-08 2009-08-05 株式会社ノエビア 細胞賦活剤
JP2004331583A (ja) * 2003-05-08 2004-11-25 Noevir Co Ltd 皮膚洗浄料
DE10330243A1 (de) * 2003-07-03 2005-01-20 bitop Aktiengesellschaft für biotechnische Optimierung Verwendung von aus extremophilen Bakterien gewonnenen Osmolyten zur Herstellung von Arzneimitteln zur äusserlichen Behandlung der Neurodermitis
DE10330768A1 (de) 2003-07-07 2005-02-24 bitop Aktiengesellschaft für biotechnische Optimierung Verwendung von aus extremophilen Bakterien gewonnenen Osmolyten zur Herstellung von inhalierbaren Arzneimitteln zur Prophylaxe und Behandlung pulmonaler und kardiovaskulärer Erkrankungen, sowie eines Osmolyte als Wirkstoffbestandteil enthaltende Inhalationsvorrichtung
WO2005053638A2 (en) 2003-11-29 2005-06-16 Passion For Life Healthcare Limited Composition and delivery system
DE102004049062A1 (de) * 2004-03-30 2005-10-13 bitop Aktiengesellschaft für biotechnische Optimierung Topische Zubereitung zur Anwendung auf der Haut enthaltend natürliches Öl der Nachtkerze (Oenothera biennis) (=Oleum Oenothera) und Osmolyte aus extremophilen Mikroorganismen
MX2007010244A (es) 2005-02-23 2008-03-10 Johnson & Johnson Administracion intranasal de agentes activos al sistema nervioso central.
JP2008537734A (ja) * 2005-03-12 2008-09-25 ビトップ アクツィエンゲゼルシャフト フュール ビオテヒニシェ オプティミールング 経口で用いられる適合溶質を含む薬剤
DE102005023639A1 (de) * 2005-05-19 2006-11-23 Beiersdorf Ag Wirkstoffkombinationen aus Glucosylglyceriden, oberflächenaktiven Glucosederivaten und Oligoglycerinderivaten
DE102005023640A1 (de) * 2005-05-19 2006-11-23 Beiersdorf Ag Wirkstoffkombinationen aus Glucosylglyceriden und einem oder mehreren partiell neutralisierten Ester von Monoglyceriden und / oder Diglyceriden gesättigter Fettsäuren mit Zitronensäure
DE102005023636A1 (de) * 2005-05-19 2006-11-23 Beiersdorf Ag Wirkstoffkombinationen aus Glucosylglyceriden und Kreatin und / oder Kreatinin
CN101453979B (zh) * 2006-04-27 2013-01-16 拜埃尔斯多尔夫股份公司 含有水通道蛋白刺激剂的化妆用制剂及其用途
JP2008024622A (ja) * 2006-07-20 2008-02-07 Noevir Co Ltd Ｉｖ型コラーゲン産生促進剤及び基底膜強化剤
AT504347B8 (de) 2006-09-21 2008-09-15 Univ Graz Tech Verfahren zur herstellung von glucosederivaten
DE102006055041A1 (de) * 2006-11-17 2008-05-21 Beiersdorf Ag Kosmetische Formulierung mit Glucosylglyceriden und kationischen Emulgatoren
DE102006056766A1 (de) * 2006-12-01 2008-06-05 Bitop Ag Verwendung von kompatiblen Soluten
DE102007040615A1 (de) * 2007-08-27 2009-03-05 Bitop Ag Osmolyte zur Behandlung von allergisch oder viral bedingten Atemwegserkrankungen
DE102007052380A1 (de) * 2007-10-31 2009-05-07 Bitop Ag Osmolythaltige Zubereitungen zur Anwendung bei trockenen Schleimhäuten
DE102008039231A1 (de) 2008-08-22 2010-02-25 Bitop Ag Verwendung von Glucosylglycerol
DE102008053549A1 (de) * 2008-10-28 2010-04-29 Bitop Ag Glucosylglycerol enthaltende Zusammensetzung
DE102011113059A1 (de) 2011-09-09 2013-03-14 Bitop Ag Therapeutische Anwendungen von Ectoin

Also Published As

Publication number Publication date
EP2328545A2 (de) 2011-06-08
WO2010020424A3 (de) 2010-04-29
US20110207681A1 (en) 2011-08-25
JP2012500781A (ja) 2012-01-12
US9867767B2 (en) 2018-01-16
WO2010020424A2 (de) 2010-02-25
US20180015017A1 (en) 2018-01-18
PL2328545T3 (pl) 2016-04-29
DE102008039231A1 (de) 2010-02-25
EP2328545B1 (de) 2015-08-05

Similar Documents

Publication Publication Date Title
BRPI0807132A2 (pt) enzimas para o tratamento de lignocelulósicos, ácidos nucléicos que codificam as mesmas, e metodos e uso das mesmas
ES2534304T3 (es) Procedimientos y composiciones que implican miARN y moléculas inhibidoras de miARN
EP2606131A4 (en) USE OF PROTEINS OF THE GLYCOSIDHYDROLASE FAMILY 61 IN THE PROCESSING OF CELLULOSE
ES2330291B1 (es) Peptidos utiles en el tratamiento de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas.
IL191759A (en) Ganaxolone formulations and methods for the making and use thereof
CL2008002381A1 (es) Oligonucleotido inmunoestimulador; composicion farmaceutica que lo comprende; y su uso para tratar un trastorno o afeccion en un sujeto, incluyendo cancer.
CL2010000188A1 (es) Metodo para el tratamiento de una infeccion en un sujeto que comprende la administracion de 9-[(2,2-dimetil-propilamino)-metil]-minociclina o de una sal de la misma; composicion farmaceutica que comprende dicho compuesto; y su uso.
BR112015014760A2 (pt) complexo de zinco-aminoácido com cisteína
BRPI0718382A2 (pt) Composições, uso das mesmas e processo para o combate de pragas animais ou fungos fitopatogênicos
MX2018011832A (es) Metodos y composiciones para uso en diagnostico de pacientes con cancer.
GT200800065A (es) Métodos y composiciones para modular la hemostasia
CL2007002376A1 (es) Compuestos derivados de pirrol sustituido; proceso de preparacion; composicion farmaceutica; y uso en enfermedades bacterianas.
CL2008001573A1 (es) Combinaciones fungicidas que contienen n-[2-(1,3-dimetilbutil)fenil]-5-fluoro-1,3-dimetil-1h-pirazol-4-carboxamida, al menos una acilalanina y al menos un derivado de estrobirulina; agentes que las comprenden; procedimiento para combatir hongos fitopatogenos en fitoproteccion; y uso de las combinaciones.
BRPI0812766A2 (pt) 4-cloro-4-alcóxi-1,1,1-triflúor-2-butanonas, preparação das mesmas e uso das mesmas no preparo de 4-alcóxi-1,1,1-triflúor-3-buten-2-onas
CR11810A (es) Compuestos de 1,2-benzotiazolo utiles para combatir plagas animales
CL2012003715A1 (es) Composicion fungicida sinergica de amplio espectro adecuada para su uso en la conservacion de un producto de madera encolada que comprende triadimefon y ciproconazol; método para la conservación de un producto de madera encolado.
WO2015028745A3 (fr) Composition cosmétique comprenant un polymère sulfonique, un polysaccharide hydrophobe et un tensioactif siliconé
NI201400065A (es) Preparaciones que comprenden emodépsido amorfo
CL2007002151A1 (es) Compuestos derivados de 1,2,4-triazol-1-il-metiloxiranos;uso de dichos compuestos para combatir hongos fitopatogenos;producto para proteccion de plantas que comprende soporte solido y uno de dichos compuestos;y procedimiento para combatir h0ngos fitopatogenos.
CL2012003080A1 (es) Compuestos derivados de alcoholes terciarios de dimetilciclohexilo, que emanan una nota de madera; composicion perfumada que los comprende; y su uso para la preparacion de una composicion tradicional de perfume, una composicion cosmetica, un producto de limpieza, entre otras.
PA8806501A1 (es) Triazolotriazinas y triazolopirazinas y su uso
FR2984735B1 (fr) Composition hydratante
ATE405326T1 (de) Kosmetiktuchprodukt
ITRM20050308A1 (it) Metodo per incrementare la sopravvivenza di ceppi batterici del genere rhizobium.
ITPD20060092A1 (it) Prodotto cosmetico o farmaceutico per uso topico